J Clin Immunol (2018) 38:129–143 https://doi.org/10.1007/s10875-017-0465-8 ORIGINAL ARTICLE The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies Aziz Bousfiha 1 & Leïla Jeddane 1,2 & Capucine Picard 3,4 & Fatima Ailal 1 & H. Bobby Gaspar 5 & Waleed Al-Herz 6 & Talal Chatila 7 & Yanick J. Crow 8,9 & Charlotte Cunningham-Rundles 10 & Amos Etzioni 11 & Jose Luis Franco 12 & Steven M. Holland 13 & Christoph Klein 14 & Tomohiro Morio 15 & Hans D. Ochs 16 & Eric Oksenhendler 17 & Jennifer Puck 18 & Mimi L. K. Tang 19,20,21 & Stuart G. Tangye 22,23 & Troy R. Torgerson 16 & Jean-Laurent Casanova 24,25,26,27 & Kathleen E. Sullivan 28 Received: 26 July 2017 / Accepted: 31 October 2017 / Published online: 11 December 2017 # The Author(s) 2017. This article is an open access publication Abstract Since the 1990s, the International Union of Immunological Societies (IUIS) PID expert committee (EC), now called Inborn Errors of Immunity Committee, has published every other year a classification of the inborn errors of immunity. This complete catalog serves as a reference for immunologists and researchers worldwide. However, it was unadapted for clinicians at the bedside. For those, the IUIS PID EC is now publishing a phenotypical classification since 2013, * Aziz Bousfiha profbousfiha@gmail.com 10 Departments of Medicine and Pediatrics, Mount Sinai School of Medicine, NewYork, NY, USA 11 Ruth’s Children’s Hospital-Technion, Haifa, Israel 12 Grupo de Inmunodeficiencias Primarias, Facultad de Medicina, Universidad de Antioquia UdeA, Medellin, Colombia 13 Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA 14 Dr von Hauner Children’s Hospital, Ludwig-Maximilians-University Munich, Munich, Germany 15 Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan 16 Department of Pediatrics, University of Washington and Seattle Children’s Research Institute, Seattle, WA, USA 17 Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, University Paris Diderot, Sorbonne Paris Cité, Paris, France 1 2 3 Laboratory of Clinical Immunology, Inflammation and Allergy LICIA, Faculty of Medicine and Pharmacy, King Hassan II University, Casablanca, Morocco Laboratoire National de Référence, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco Center for the Study of Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris(APHP), Paris, France 4 Laboratory of Lymphocyte Activation and Susceptibility to EBV, INSERM UMR1163, Imagine Institute, Necker Hospital for Sick Children, Paris Descartes University, Paris, France 5 UCL Great Ormond Street Institute of Child Health, London, UK 6 Department of Pediatrics, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait 18 Division of Immunology, Children’s Hospital Boston, Boston, MA, USA Department of Pediatrics, University of California San Francisco and UCSF Benioff Children’s Hospital, San Francisco, CA, USA 19 Murdoch Children’s Research Institute, Melbourne, VIC, Australia 20 Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia 21 Department of Allergy and Immunology, Royal Children’s Hospital, Melbourne, Australia 22 Immunology Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia 23 St Vincent’s Clinical School, University of NSW, Sydney, Australia 7 8 9 Laboratory of Neuroinflammation and Neurogenetics, Necker Branch, INSERM UMR1163, Sorbonne-Paris-Cité, Institut Imagine, Paris Descartes University, Paris, France Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK 130 J Clin Immunol (2018) 38:129–143 which proved to be more user-friendly. There are now 320 single-gene inborn errors of immunity underlying phenotypes as diverse as infection, malignancy, allergy, auto-immunity, and auto-inflammation. We herein propose the revised 2017 phenotypic classification, based on the accompanying 2017 IUIS Inborn Errors of Immunity Committee classification. Keywords Primary immunodeficiencies . Classification . Phenotypic . IUIS . Inborn errors of immunity Human primary immunodeficiency diseases (PID) comprise 330 distinct disorders with 320 different gene defects listed [1]. Long considered as rare diseases, recent studies tend to show that they are more common than generally thought, if only by their rapidly increasing number [2, 3].The International Union of Immunological Societies (IUIS) PID expert committee proposed a PID classification since 1999 [1], which facilitates clinical research and comparative studies worldwide; it is updated every other year to include new disorders or disease-causing genes. This classification is organized in tables, each of which groups PIDs that share a given pathogenesis. As this catalog is not adapted for use by the clinician at the bedside, the now called Inborn Errors of Immunity Committee proposed since 2013 a phenotypic complement to its classification [4]. Moreover, a smartphone application has been published, based on the 2015 phenotypic classification [5]. As the number of inborn errors of immunity is quickly increasing, 24 St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA 25 Howard Hughes Medical Institute, New York, NY, USA 26 Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Imagine Institute, Necker Hospital for Sick Children, University Paris Descartes, Paris, France 27 Pediatric Hematology-Immunology Unit, Necker Hospital for Sick Children APHP, Paris, France 28 Division of Allergy Immunology, Department of Pediatrics, The Children’s Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA Fig. 1 Immunodeficiencies affecting cellular and humoral immunity. a„ Severe combined immunodeficiencies defined by T cell lymphopenia. b Combined immunodeficiencies. * T cell lymphopenia in SCID is defined by CD3+ T cells < 300/µL. AD: autosomal dominant transmission; ADA: adenosine deaminase; Ag: antigen; AR: autosomal recessive transmission; β2m: bêta-2 microglobulin; Bc: B cells; CBC: complete blood count; CD: cluster of differentiation; CVID: common variable immunodeficiency; def: deficiency; EBV: Epstein Barr virus; HHV8: human herpes virus 8; HIGM: hyper IgM syndrome; HPV: human papillomavirus; Ig: immunoglobulins; MHC: major histocompatibility complex; Nl: normal; NK: natural killer; SCID: severe combined immunodeficiency; Tc: T cells; TCR: T cell receptor; Treg: regulatory T cells; XL: X-linked transmission and at an even faster pace since the advent of next-generation sequencing, this phenotypic classification requires revision at the same pace as the classical IUIS classification. Here, we present an update of these figures (Figs. 1, 2, 3, 4, 5, 6, 7, 8, and 9), based on the accompanying 2017 report in inborn errors of immunity. We included all diseases included in the 2017 update of the IUIS classification [1] and split some categories in two parts to ease the lecture. An algorithm was assigned to each of the nine main groups of the classification and the same color was used for each group of similar conditions. Disease names are presented in red and genes in bold and italics. Mode of inheritance is expressed when adequate; if not expressed, the default mode of transmission is autosomal recessive. Clinical features that point to several diseases are presented in italics before the disease names. J Clin Immunol (2018) 38:129–143 131 I. Immunodeficiencies affecng cellular and humoral immunity. (a) Severe combined immunodeficiencies SCID, defined by CD3 T cell lymphopenia*. CD19 NL : SCID T- B+ SCID T-B+NK- CD19 ↓ : SCID T-B- SCID T-B+NK+ SCID T-B-NK- SCID T-B-NK+ ADA def . ADA Microcephaly ? XL, IL7R . Coronin-1A CD 132- IL7R def . CORO1A Chondrosternal Detectable dysplasia, c deficiency. IL2RG No γ/δ T cells: CD3δ. CD3D CD3ε. CD3E AR, CD3ζ . CD247 CD 132+ Nl γ/δ T cells : JAK-3 def. JAK3 thymus Winged helix def. FOXN1. Severe deafness, may have pulmonary alveolar proteinosis, cognive defects infecons; thymic Recular dysgenesis. AK2 epithelium; Granulocytopenia, congenital Thrombocytopenia abnormal CD45 def. PTPRC alopecia, nail Yes - With facial dysmorphism: DNA ligase IV def . LIG4 CERNUNNOS /XLF def. NHEJ1. Radiaon sensive No RAG 1/2 def. (RAG1/ RAG2) DCLRE1C def. DCLRE1C (ARTEMIS). Radiosensibility - Without facial dysmorphism: deafness. dystrophy, DNA PKcs def. PRKDC Radiosensibility neural tube defect. I. Immunodeficiencies affecng cellular and humoral immunity (b) Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency Low CD4: MHCII Expression ? Absent : Low CD8 Present: XL MAGT1 def. MHC-II def. RFXANK,CIITA, RFX5, RFXAP MAGT1. AR, LCK def. LCK. Low Bc: DOCK8 def. DOCK8.Severe Eczema. Cutaneous viral and staphylococcal infecons; severe atopy; cancer ,diathesis. High IgE, Low IgM, eosinophilia. Low NK with poor funcon. Low CD27+ memory Bc Poor peripheral Bc tolerance. Ig : o en NL CD3γ def. CD3G TCR low. RHOH def. RHOH. HPV autoimmunity. Low respiratory Treg, restricted T cell infecons, repertoire, poor TCR liver/biliary tract signaling; disease AD :UNC119 def. UNC119 CD8 def . CD8A Maybe asymptomac. CD8 Absent. Nl MHC I on lymphocytes. ZAP-70 def. ZAP70 May have immune dysregulaon, autoimmunity. Nl Ig. CD4: Low foncon MST1 def . STK4.Intermient neutropenia; bacterial, viral (HPV), candidal infecons; EBV lymphoproliferaon; autoimmune cytopenias; lymphoma; congenital heart disease. Low T and B. High Ig. Low terminal differenated effector memory cells, low naïve Tc, poor proliferaon. hematopoiec and non-hematopoiec cells. IgG IL21R def . IL21R. Recurrent NL or low; poor anbody responses. infecons; lymphoma. Low naïve T cells, restricted repertoire, poor proliferaon to CD3. TCRα def .TRAC. Recurrent viral, bacterial, CARD11 deficiency (LOF). CARD1. Pneumocyss jirovecii pneumonia, bacterial & viral infecons .Ig:Absent/low.Tc:NL number, poor proliferaon BCL10 def. BCL10. Recurrent bacterial and viral fungal infecons; immune infecons, candidiasis, gastroenteris. Low dysregulaon and memory T and Treg cells, poor Ag and an-CD3 autoimmunity; diarrhea. prolif. Decreased memory and switched Bc Absent TCRαβ; all Tc are γδ; poor proliferaon. IKBKB def. IKBKB. Recurrent bacterial, viral and fungal infecons. Opportunisc infecons. Bc : BCL11B deficiency. BCL11B. AD. Congenital teeth, dysmorphic facies; absent corpus callosum; poor foncons. absent Treg and γδ T cells; impaired TCR acvaon. ICOS def. ICOS. Autoimmunity, gastroenteris, granulomas (CVID). neurocognive deficits. Tc : NIK def. MAP3K14. Bacterial, viral and Cryptosporidium infecons. Low NK and Ig levels. Low switched memory Bc. Tc :Ag poor proliferaon Absent MHC I on lymphocytes. Low, poor proliferaon. TFRC deficiency. TFRC. Neutropenia, thrombocytopenia. Bc:Nl number, low memory Bc. Tc: Nl number, poor proliferaon . OX40 def. OX40. Kaposi’s sarcoma, impaired immunity to HHV8. Low RelB deficiency.RELB.Tc:poor diversity, poor funcon memory Bc. Tc : low Ag MHC-I def . Moesin def. MSN. XL, TAP2, TAP1 or TAPBP Recurrent infecons with Vasculis, pyoderma gangrenosum. Nl Ig. bacteria, varicella; B2M neutropenia. Low Ig over Sinopulmonary infecons, cutaneous granulomas. me. Tc: defecve Nl Ig. Hypoprodemia. Absent β2m associated migraon, proliferaon. proteins MHC-I, CD1a, CD1b, CD1c. funcon. Poor interferon responses in molluscum contagiosum, abnormalies: neonatal IL21 def. IL21. Severe early onset colis. Low IgG. Tc : NL / low funcon. DOCK2 def. DOCK2. Low Tc; NL NK but defecve Normal Ig but Poor Specific Anbody response infecon, lung granulomas, Immune dysregulaon, Diarrhea, Ig Low specific memory CD4+. CD40 ligand def. (CD154). XL, CD40LG. or CD40 def. AR, CD40. Opportunisc infecons, biliary LAT def . LAT. Adenopathy, splenomegaly, autoimmunity. High Ig . T and B : NL to low tract and liver disease, Cryptosporidium. HIGM. Neutropenia, thrombocytopenia, hemolyc anemia, IgM normal or high, other Ig isotypes low. Bc: sIgM+, IgD+ cells present, absent sIgG+, IgA+ and IgE+ cells. Tc: NL to low. Pneumocyss, Cryptosporidium. Tc: low cytokine producon; poor angen proliferaon. MALT1 def. MALT1. Bacterial, fungal and viral infecons. Impaired Tc proliferaon and anbody response 132 J Clin Immunol (2018) 38:129–143 IIa. CID with associated or syndromic features Congenital thrombocytopenia DNA Repair Defects other than those listed in Table1: Karyotype XL: Wisko Aldrich Sd . WAS (LOF). XL thrombocytopenia is a mild form of WAS. Recurrent bacterial and viral infecons; bloody diarrhea; eczema; lymphoma; autoimmune disease; IgA nephropathy; vasculis. Small platelets; Decreased IgM. Low anbody to polysaccharides; o en increased IgA and IgE. Nl Bc. Tc: Progressive decrease in numbers; Low Tc responses to an-CD3. AR: WIP deficiency. WIPF1, Recurrent bacterial and viral infecons; eczema; bloody diarrhea . WAS protein absent. +/- small platelets; increased IgE. Bc : Nl to low. Tc: Reduced; defecve lymphocyte responses to an-CD3. AR: ARPC1B deficiency. ARPC1B. Recurrent invasive infecons, colis, vasculis. Mild thrombocytopenia, normal sized platelets; autoanbodies (ANA, ANCA); eosinophilia; defecve Arp2/3, filament branching. High IgA and IgE. Ataxia telangiectasia. ATM: Ataxia; telangiectasia; pulmonary infecons; lymphorecular and other malignancies; increased αfetoprotein; increased radiosensivity, chromosomal instability and translocaons. O en decreased IgA, IgE and IgG subclasses; increased IgM; anbodies variably decreased. Tc : Progressive decrease, abnormal proliferaon to Mitogens. Nijmegen breakage sd. NBS1. Microcephaly; bird-like face; lymphomas; solid tumors; increased radiosensivity; chromosomal instability. O en decreased IgA, IgE and IgG subclasses;increased IgM; anbodies variably decreased. Bc: Variably reduced. Tc: progressive decrease. Bloom sd. BLM.Short stature; bird like face; sun-sensive erythema; marrow failure; leukemia; lymphoma; chromosomal instability. Low Ig. PMS2 def. PMS2. Café-au-lait spots ; lymphoma, colorectal carcinoma, brain tumors. HIGM and abnormal anbody responses. Reduced Bc, switched and non-switched. Immunodeficiency with centromeric instabily and facial anomalies. ICF1. DNMT3B; ICF2:ZBTB24; ICF3:CDCA7; ICF4:HELLS.Facial dysmorphism; macroglossia; bacterial/opportunisc infecons; malabsorpon; malignancies. Cytopenias; mulradial configuraons of chromosomes 1,9,16; no DNA breaks. Ig: Hypogammaglobulinemia; Tc and Bc: decreased or Nl. Immunoosseous dysplasias Carlage Hair Hypoplasia. RMRP.Short-limbed dwarfism with metaphyseal dysostosis, sparse hair, bone marrow failure; autoimmunity; suscepbility to lymphoma and other cancers; impaired spermatogenesis; neuronal dysplasia of the intesne. Ig: Normal or reduced. Tc: Varies from severely decreased (SCID) to normal; impaired lymphocyte proliferaon. Schimke sd. SMARCAL1 Short stature, spondyloepiphyseal dysplasia, IUGR; nephropathy; bacterial, viral, fungal infecons; may present as SCID; bone marrow failure. Tc: Decreased. MCM4 def. MCM4. Viral infecons:EBV,HSV,VZV.Short stature.Bc lymphoma; Adrenal failure; NKc low number and funcon. RNF168 def. RNF168. Short stature; mild defect of motor control to ataxia; normal intelligence to learning difficules; mild facial dysmorphism to microcephaly; increased radiosensivity ( = Riddle Sd). Low IgG or IgA. POLE1 (Polymerase ε subunit 1) deficiency . POLE1.Recurrent respiratory infecons; meningis; facial dysmorphism, livido, short stature (FILS syndrome). Low IgM, lack of anbody to PPS. Low memory Bc. Decreased Tc proliferaon. POLE2 (Polymerase ε subunit 2) deficiency. POLE2. Recurrent infecon, systemic BCG infecons, autoimmunity (type 1 diabetes, hypothyroidism), facial dysmorphism; Low Ig; Very low Bc. Lymphopenia, lack of TRECS, absent proliferaon of angens. NSMCE3 deficiency. NSMCE3. Severe lung disease (possibly viral); thymic hypoplasia, Chromosomal breakage; radiaon sensivity. Ig: Decreased Ab responses to PPS, normal IgG, IgA, elevated IgM. Tc : Number decreased, poor response to mitogens and angens. ERCC6L2 (Hebo deficiency). ERCC6L2. Facial dysmorphism; microcephaly, bone marrow failure. Low Bc, Nl Ig. Lymphopenia. Ligase I deficiency . LIGI Recurrent respiratory infecons; growth retardaon; sun sensivity; lymphoma; radiaon sensivity. Low IgA and IgG. Reduced anbody responses. Lymphopenia, decreased mitogen response. MYSM1 deficiency. MYSM1. Short stature, congenital bone marrow failure, myelodysplasia, Skeletal anomalies; cataracts; developmental delay. Affects granulocytes. Bc: immature. Tc: lymphopenia, reduced naïve Tc. Hypogammaglobulinemia. Thymic Defects with Addional Congenital Anomalies AD. Hypoparathyroidism, conotruncal cardiac malformaon, velopalatal insufficiency, facial dysmorphism, intellectual disability . Ig : Normal or decreased. Tc: Decreased or Nl : DiGeorge/velocardiofacial Sd. Chr22q11.2 deleon Sd. 22q11.2DS. TBX1 deficiency . TBX1 + Renal disease, deafness. Chromosome 10p13-p14 deleon Syndrome. 10p13-p14DS. AD. CHARGE sd. CHD7, SEMA3E. Coloboma, heart anomaly, choanal atresia, intellectual disability, genital and ear anomalies; CNS malformaon; some are SCIDlike and have low TRECs. Ig: Normal or decreased. Tc: Decreased or normal; response to PHA may be decreased MOPD1 Deficiency. RNU4ATAC.Recurrent bacterial infecons, lymphadenopathy, Spondyloepiphyseal dysplasia, IUGR, renal dystrophy, facial dysmorphism; +/- microcephaly. Ig: NL specific anbodies variably decreased. EXTL3 Deficiency. EXTL3. Platyspondyly, kyphosis, variable skeletal dysplasias, developmental delay Ig: variably decreased. Tc: reduced. GINS1 def. GINS1. IUGR. Neutropenia, NK cells very low. Tc: and Bc low or normal. High IgA, Low IgG and IgM. Fig. 2 a, b CID with associated or syndromic features. Ab: antibody; AD: autosomal dominant transmission; ANA: anti-nuclear antibodies; ANCA: anti-neutrophil cytoplasm antibodies; AR: autosomal recessive transmission; Bc: B cells; BCG: Bacillus Calmette-Guerin; BCR: B cell receptor; CD: cluster of differentiation; CMV: cytomegalovirus; CNS: central nervous system; def: deficiency; DNA: desoxyribonucleic acid; DKC: dyskeratosis congenita; EDA: anhidrotic ectodermal dysplasia; GOF: gain-of-function; HIES: hyper IgE syndrome; FILS: facial dysmorphism, immunodeficiency, livedo and short stature; ID: immunodeficiency; Ig: immunoglobulins; IUGR: intrauterine growth retardation; LOF: loss-of-function; MDS: myelodysplasia; Nl: normal; NK: natural killer; PHA: phytohemagglutinin; PPS: polysaccharides; SCID: severe combined immunodeficiency; sd: syndrome; Tc: T cells; TCR: T cell receptor; TREC: T cell receptor excision circle; XL: X-linked transmission J Clin Immunol (2018) 38:129–143 133 IIb. CID with associated or syndromic features Hyper-IgE syndromes (HIES) AD-HIES (Job sd). STAT3, LOF. Disncve facial features (broad nasal bridge); bacterial infecons (boils and pulmonary abscesses, pneumatoceles) due to S. aureus, Aspergillus, Pneumocyss jirovecii; eczema; mucocutaneous candidiasis; hyperextensible joints, osteoporosis and bone fractures, scoliosis, retenon of primary teeth; aneurysm formaon Ig:Elevated IgE; specific anbody producon decreased. Bc:Normal; reduced switched and non-switched memory Bc; BAFF expression increased. Tc:Nl overall; Th-17 and T-follicular helper cells decreased. Comel Netherton sd. SPINK5; Congenital ichthyosis, bamboo hair;,atopic diathesis; increased bacterial infecons. Elevated IgE and IgA; Other Ig: variably decreased. Bc: Switched and non-switched Bc are reduced. PGM3 deficiency. PGM3. Severe atopy; autoimmunity; Immunoosseous dysplasias. Recurrent pneumonia, recurrent skin abscesses,bacterial and viral infecons; cognive impairment; hypomyelinaon. Ig:Nl or elevated. Elevated IgE; eosinophilia. Reduced B and memory Bc. CD8 and CD4 Tc may be decreased. Dyskeratosis congenita (DKC) Myelodysplasia, defecve telomere maintenance Defects of Vitamin B12 and Folate Metabolism: Anhidroc Ectodermodysplasia with ID Exclude other causes: Fanconi anemia, Blackfan-Diamond Megaloblasc anemia, Ig: decreased. Transcobalamin 2 deficiency. TCN2. pancytopenia, if untreated for prolonged periods results in intellectual disability. Anhidroc ectodermal dysplasia,various infecons (bacteria, mycobacteria, viruses and fungi), colis, variable defects of skin, hair and teeth. Dyskeratosis congenita. IUGR, microcephaly, nail dystrophy, sparse scalp hair and eyelashes; poikiloderma or abnormal skin pigmentaon; palmar hyperkeratosis; premalignant oral leukoplakia; pancytopenia; +/recurrent infecons. A severe phenotype with developmental delay and cerebellar hypoplasia known as Hoyeraal-Hreidarsson Syndrome (HHS) may occur in some paents. Ig and Bc: variable. DKC1: XL, Bc and Tc: Progressive decrease. NOLA2 (NHP2), NOLA3 (NOP10): AR, Tc: Decreased. RTEL1 : AD/AR, Tc: Decreased. TERC, TINF2: AD,Tc: variable. TERT, TPP1: AD/AR, Tc: variable. DCLRE1B/ SNM1/APOLLO, PARN, WRAP53: AR,Tc: variable. COATS plus Sd. Intracranial calcificaon, abnormal telomeres, IUGR, gastrointesnal hemorrhage due to vascular ectasia, hypocellular bone marrow. pancytopenia STN1: premature aging, CTC1 : sparse graying hair, dystrophic nails, osteopenia, renal telangiectasia SAMD9. AD. SAMD9 (GOF) : IUGR with gonadal abnormalies, adrenal failure, MDS with chromosome 7 aberraons, predisposion to infecons, enteropathy, absent spleen SAMD9L. AD. SAMD9L. (GOF) :Cytopenia, predisposion to MDS with chromosome 7 aberraons and progressive cerebellar dysfuncon Deficiency causing hereditary folate malabsorbon. SLC46A1. if untreated for prolonged periods results in intellectual disability Methylenetetrahydrofolate dehydrogenase 1 deficiency. MTHFD1.Recurrent bacterial infecon, Pneumocyss jirovecii, neutropenia, seizures, intellectual disability, folate-responsive, poor anbody responses to conjugated polysaccharide angens. Low Bc. NEMO deficiency. IKBKG (NEMO). XL, monocyte dysfuncon. Ig decreased, some with elevated IgA, IgM, poor specific anbody responses, absent anbody to polysaccharide angens. Bc: Nl, Low memory and isotype switched Bc. Tc: Nl/decreased, TCR acvaon impaired. EDA-ID due to IKBA GOF mutaon. NFKBIA (IKBA). AD Tc and monocyte dysfuncon Decreased IgG and IgA, elevated IgM, poor specific anbody responses, absent anbody to polysaccharide angens. Normal Bc numbers, impaired BCR acvaon, low memory and isotype switched Bc. Normal total Tc, TCR acvaon impaired. Others Purine nucleoside phosphorylase deficiency. PNP. Autoimmune hemolyc anemia, neurological impairment. Hypouricemia. Ig : Nl/Low. Bc: Nl. Tc: Progressive decrease ID with mulple intesnal atresias. TTC7A . Bacterial (sepsis), fungal, viral infecons, mulple intesnal atresias, o en with intrauterine polyhydramnios and early demise, some with SCID phenotype. Markedly decreased IgG, IgM, IgA. Bc:Nl/low.Tc: Variable/absent,low TRECs. Hepac veno-occlusive disease with immunodeficiency (VODI). SP110. Hepac veno-occlusive disease, Pneumocyss jirovecii pneumonia, CMV, candida, thrombocytopenia, hepatosplenomegaly, cerebrospinal leukodystrophy. Decreased IgG, IgA, IgM, absent germinal centers and ssue plasma cells. Decreased memory Bc . Decreased memory Tc. Vici syndrome. EPG5. Agenesis of the corpus callosum, cataracts, cardiomyopathy,skin hypopigmentaon, intellectual disability, microcephaly, CMC. Ig: Decreased IgG2. Bc: Defecve. Profound depleon of CD4+ cells. Bacterial infecons, autoinflammaon, amylopecnosis.Bc: Nl,decreased memory Bc. HOIL1 deficiency. HOIL1 (RBCK1). Poor anbody responses to polysaccharides. HOIP deficiency. HOIP1 (RNF31). Lymphangiectasia. Ig: decreased. Calcium Channel Defects. Autoimmunity, EDA, non-progressive myopathy. Ig and Bc: Nl. Tc: Normal, defecve TCR mediated acvaon. ORAI-1 deficiency. ORAI1 . STIM1 deficiency. STIM1 Hennekam-lymphangiectasia-lymphedema syndrome. CCBE1. Lymphangiectasia and lymphedema with facial abnormalies and other dysmorphic features. Ig: decreased. Bc and Tc: Variable. STAT5b deficiency. STAT5B. Growth-hormone insensive dwarfism, dysmorphic features, eczema, lymphocyc intersal pneumonis, autoimmunity. Kabuki Sd. Typical facial abnormalies, cle or high arched palate, skeletal abnormalies, short stature, intellectual disability, congenital heart defects, recurrent infecons (os media, pneumonia) in 50% of paents. Autoimmunity may be present. Low IgA and occasionally low IgG. KMT2D (MLL2): AD. KDM6A: XL. Fig. 2 (continued) 134 J Clin Immunol (2018) 38:129–143 III. Predominantly Antibody deficiencies, a: Hypogammaglobulinemia Serum Immunoglobulin Assays : IgG, IgA, IgM, IgE IgG, IgA and/or IgM Exclude second causes: drugs [Hx], myeloma [bone marrow], lymphoma. Ig loss (not hypo-IgM) in urine, gastro-intestinal or skin. → B Lymphocyte (CD19+) enumeration (CMF) B absent B >1 % Severe bacterial infection. All Ig isotypes decreased. X-Linked Agammaglobulinemia. BTK. Some patients have detectable Ig. ProBc: Nl AR : μ heavy chain Def. IGHM Igα def. CD79A, Igβ def. CD79B BLNK def. BLNK, λ5 def. IGLL1 ProBc: Nl PI3KR1 def. PIK3R1. ProBc: Decreased AD E47 transcription factor def. TCF3. Commun Variable Immunodeficiency Phenotype CVID with no gene defect specified. Clinical phenotypes vary: most have recurrent infecons, some have polyclonal lymphoproliferaon, autoimmune cytopenias and/or granulomatous disease AD. Severe bacterial infecons; EBV suscepbility. PIK3CD mutaon (GOF). PIK3CD GOF. Decreased pro-Bc. PIK3R1 deficiency (LOF). PIK3CD. Pro-Bc present and low memory Bc. PTEN Deficiency (LOF). PTEN. AD. Lymphoproliferaon, Autoimmunity. CD81 deficiency. CD81. Recurrent infecons, may have glomerulonephris. TACI deficiency. TNFRSF13B (TACI). AD or AR . Variable clinical expression BAFF receptor deficiency. TNFRSF13C (BAFF-R). Variable clinical expression. Low IgG and IgM. TWEAK deficiency. TWEAK (TNFSF12). AD. Pneumonia, bacterial infecons, warts, thrombocytopenia. Neutropenia. Low IgM and A, lack of an-pneumococcal anbody. Mannosyl-oligosaccharide glucosidase deficiency (MOGS). MOGS (GCS1). Bacterial and viral infecons, severe neurologic disease, also known as congenital disorder of glycosylaon type IIb (CDG-IIb). Severe hypogammagl. TTC37 deficiency. TTC37 . Recurrent bacterial and viral infecons, Abnormal hair findings: trichorrhexis nodosa. Poor anbody response to pneumococcal vaccine. IRF2BP2 deficiency. IRF2BP2. Recurrent infecons, possible autoimmunity and inflammatory disease. Hypogammaglobulenia, absent IgA. CD19 deficiency. CD19. Recurrent infecons, may have glomerulonephris. CD20 deficiency. CD20.Recurrent infecons. Low IgG, Nl or elevated IgM and IgA. CD21 deficiency. Recurrent infecons. Low IgG, impaired an-pneumococcal response. TRNT1 deficiency. TRNT1. Congenital sideroblasc anemia, deafness, developmental delay. B cell deficiency and hypogammagl. NFKB1 deficiency. NFKB1. AD. Recurrent sinopulmonary infecons, COPD, EBV proliferaon, autoimmunity, autoinflammaon. Ig normal or low, Bc low or normal, low memory Bc. NFKB2 deficiency. NFKB2. AD. Recurrent sinopulmonary infecons, alopecia and endocrinopathies (ie, central adrenal insufficiency). Low Bc. IKAROS deficiency. IKZF1. AD. Recurrent sinopulmonary infecons. Low or normal Bc potenally reducing levels with age. ATP6AP1 deficiency. ATP6AP1. XL. Hepatopathy, leukopenia, low copper. Leukopenia and hypogammagl. III. Predominantly Antibody deficiencies. b: Other Anbody deficiencies Serum Immunoglobulin Assays : IgG, IgA, IgM, IgE Severe Reducon in Serum IgG and IgA with Isotype, Light Chain, or Funconal Deficiencies with Generally Nl Numbers of Bc High Bc numbers due to constuve NF-κB acvaon Nl/elevated IgM and Normal Numbers of Bc : Hyper IgM Syndromes AID deficiency. AICDA. Bacterial infecons, enlarged lymph nodes and germinal centers. UNG deficiency. UNG. Enlarged lymph nodes and germinal centers. INO80. INO80 . Severe bacterial infecons. Selecve IgA deficiency. Unknown. Bacterial infecons, autoimmunity mildly increased. Very low to absent IgA with other isotypes normal, normal subclasses and specific anbodies. CARD11 GOF . Transient hypogammaglobuliemia of infancy. Unknown. Usually not associated with significant infecons, normal ability to produce anbodies to vaccine angens. IgG and IgA decreased. Splenomegaly, IgG subclass deficiency with IgA deficiency. Unknown. Recurrent bacterial infecons. Reduced IgA with decrease in one or more IgG subclass. Isolated IgG subclass deficiency. Unknown. Usually asymptomac, a minority may have poor anbody response to specific angens and recurrent viral/bacterial infecons. Reducon in one or more IgG subclass. MSH6. MSH6 . Family or personal history of cancer. Variable IgG, defects, increased IgM in some, Nl Bc, low switched memory Bc. Specific anbody deficiency with normal Ig levels and normal B cells. Unknown. Reduced ability to produce anbodies to specific angens. Ig: Nl. Ig heavy chain mutaons and deleons. Mutaon or chromosomal deleon at 14q32. May be asymptomac. One or more IgG and/or IgA subclasses as well as IgE may be absent. Kappa chain deficiency. IGKC. Asymptomac. All immunoglobulins have lambda light chain. Selecve IgM deficiency. Unknown. Pneumococcal / bacterial infecons. Absent serum IgM. CARD11. AD. BENTA syndrome lymphadenopathy, poor vaccine responses. J Clin Immunol (2018) 38:129–143 135 ƒFig. 3 Predominantly antibody deficiencies. a Hypogammaglobulinemias. b Other antibody deficiencies. AD: autosomal dominant transmission; AR: autosomal recessive transmission; Bc: B cells; BENTA: B cell expansion with NF-κB and T cell anergy; CD: cluster of differentiation; CMF: flow cytometry; COPD: chronic obstructive pulmonary disease; def: deficiency; EBV: Epstein Barr virus; GOF: gain-of-function; Hx: patient history; Ig: immunoglobulins; Nl: normal; XL: X-linked transmission Compliance with Ethical Standards IV. Diseases of immune dysregulaon. a : Hemophagocyc Lymphohisocytosis HLH & EBV suscepbility Hemophagocyc Lymphohisocytosis (HLH) Hypopigmentaon: Paral albinism . Decreased NK and CTL acvies(cytotoxicity and/or degranulaon). Bc and Tc: Nl Chediak Higashi sd. LYST Recurrent infecons, fever, (H)SM, bleeding tendency, progressive dysfuncon. Giant Suscepbility to EBV Familial Hemophagocyc Lymphohisocytosis Syndromes: Fever, (H)SM, cytopenias, Nl Bc. Increased acvated Tc. Decreased to absent NK and CTL acvies cytotoxicity. CD70 deficiency. CD70 (TNFSF7). Hodgkin’s lymphoma. Reduced IgM, IgG, IgA (75%) and reduced Ag-specific Ab responses (50%). Bc:poor anbody and memory responses. Tc:low Treg, poor acvaon and funcon Perforin deficiency (FHL2).PRF1. neurological lysosomes (WBC), RASGRP1 deficiency. RASGRP1. Recurrent pneumonia, herpes virus infecons, EBV associated lymphoma. Increased IgA. Bc and Tc: Poor acvaon, proliferaon, molity UNC13D / Munc13-4 deficiency (FHL3). UNC13D. neutropenia, cytopenias, Specific hair sha anomaly. Syntaxin 11 deficiency (FHL4). STX11. Griscelli sd type 2. RAB27a. STXBP2 / Munc18-2 deficiency (FHL5) STXBP2. Enteropathy CTPS1 deficiency. CTPS1. Recurrent/chronic bacterial and viral infecons (EBV, VZV), EBV lymphoproliferaon, Bc non-Hodgkin lymphoma. Tc: poor proliferaon to Ag Fever, (H)SM, cytopenias; Specific hair sha RLTPR (CARMIL2) deficiency. RLTPR. Recurrent bacterial, fungal and mycobacterial infecons, viral warts, molluscum and EBV lymphoproliferave and other malignancy, atopy. Ig Nl to low, poor T dependent anbody response. Nl Bc. Tc: low Treg, high CD4, poor funcon. anomaly. Hermansky Pudlak sd type 2. AP3B1. Recurrent infecons, pulmonary fibrosis, increased bleeding, neutropenia; Specific hair sha anomaly. Hermansky-Pudlak sd, type 10. AP3D1. Oculocutaneous albinism, severe neutropenia, recurrent infecons, seizures, hearing loss and neurodevelopmental delay . ITK deficiency. ITK . EBV associated Bc lymphoproliferaon, lymphoma, Nl or low IgG. Tc: Progressive decrease MAGT1 deficiency (XMEN). MAGT1.XL. EBV infecon, lymphoma, viral infecons, respiratory and GI infecons. Low CD4 Low recent thymic emigrant cells, poor proliferaon to CD3 PRKCD deficiency. PRKCD. Recurrent infecons, EBV chronic infecon, lymphoproliferaon, SLE-like autoimmunity (nephroc and anphospholipid Sd). Low IgG. Low memory Bc high CD5 Bc Fig. 4 Diseases of immune dysregulation. a Hemophagocytic lymphohistiocytosis. b Other diseases of immune dysregulation. Ab: antibody; AD: autosomal dominant transmission; Ag: antigen; ALPS: autoimmune lymphoproliferative syndrome; APS: autoimmune polyendocrinopathy syndrome; AR: autosomal recessive transmission; Bc: B cells; CD: cluster of differentiation; CMF: flow cytometry; CTL: cytotoxic T lymphocytes; def: deficiency; DNT: double negative T cells; EBV: Epstein EBV associated HLH XL, XLP1. SH2DIA. Clinical and immunologic features triggered by EBV infecon: lymphoproliferaon, Lymphoma. Hypogamma globulinemia, Absent iNKT cells. Impaired NK cell and CTL cytotoxic acvity . Reduced Memory B cells . SAP deficiency (CMF). XL, XLP2. XIAP. Splenomegaly, lymphoproliferaon, Colis, IBD, hepas. Hypogammaglobulinemia, Low iNKT cells. Increased T cells suscepbility to apoptosis to CD95 and enhanced acvaon-induced cell death (AICD). Normal NK and CTL cytotoxic acvity. XIAP def (CMF) AR, CD27 deficiency . CD27 (TNFRSF7). Features triggered by EBV infecon, aplasc anemia, low iNKTc lymphoma. Low Ig FAAP24 deficiency. FAAP24. EBV-driven lymphoproliferave disease. Failure to kill autologous EBV transformed Bc. Barr virus; FHL: familial hemophagocytic lymphohistiocytosis; GOF: gainof-function; HLH: hemophagocytic lymphohistiocytosis; (H)SM: (hepato)splenomegalia; IBD: inflammatory bowel disease; Ig: immunoglobulin; IL-10: interleukin-10; LOF: loss-of-function; iNKT: invariant NKT cells; NK: natural killer cells; Nl: normal; sd: syndrome; SLE: systemic lupus erythematous disease; Tc: T cells; TCR: T cell receptor; XL: X-linked transmission 136 J Clin Immunol (2018) 38:129–143 IV. Diseases of immune dysregulaon. b: Sd with Autoimmunity and Others Syndromes with Autoimmunity Immune Dysregulaon with Colis:IBD , Nl Tc & Bc Increased CD4-CD8-TCR α/β (double negative (DN) T cells) ? Yes Occasionnally ALPS Autoimmune Lymphoproliferative Sd LRBA deficiency. LRBA. AR. Chronic adenopathy Splenomegaly, defective lymphocyte apoptosis. ALPS-FAS. TNFRSF6. AD or AR. Autoimmune cytopenias, increased lymphoma risk, IgG and IgA Nl or increased, elevated serum FasL, IL-10, vitamin B12. ALPS-FASLG. TNFSF6.AR. autoimmune cytopenias, SLE, soluble FasL is not elevated ALPS-Caspase10. CASP10. AD. ALPS-Caspase 8. CASP8. AR. Bacterial and viral infecons, Hypogammaglobulinemia. Defecve lymphocyte acvaon. Slightly increased DNT cells. FADD deficiency. FADD. AR. Funconal hyposplenism, bacterial and viral infecons, recurrent episodes of encephalopathy and liver dysfuncon. IL-10 deficiency. IL10. AR. No: Regulatory T Cell Defects ? Folliculis, recurrent respiratory diseases, arthris. No funconal IL- Autoimmune cytopenias, enteropathy, intersal lung disease, extralymphoid lymphocyc infiltraon, recurrent infecons. Reduced IgG and IgA in most. Low or normal numbers of Bc. Normal or decreased CD4 numbers, Tc dysregulaon. STAT3 GOF mutaon. STAT3. AD. Lymphoproliferaon, solid organ autoimmunity, recurrent infecons. Enhanced STAT3 signaling, leading to increased Th17 cell differenaon, lymphoproliferaon and autoimmunity. Decreased Tregs and impaired funcon. Tc and Bc decreased. No Yes Autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy: APECED (APS-1) . AIRE. AR/ AD. Hypoparathyroidism hypothyroidism, adrenal insufficiency, diabetes, gonadal dysfuncon and other endocrine abnormalies, chronic mucocutaneous candidiasis, dental enamel hypoplasia, alopecia, enteropathy, pernicious anemia. IPEX, immune dysregulaon, polyendocrinopathy, enteropathy X-linked. FOXP3. Autoimmune enteropathy, early onset diabetes, thyroidis hemolyc anemia, thrombocytopenia, eczema, elevated IgE, IgA. Lack and/or impaired funcon of CD4+ CD25+ FOXP3+ regulatory T cells (Tregs). ITCH deficiency. ITCH. AR. Early-onset chronic lung disease (intersal pneumonis), thyroidis, type I diabetes, chronic diarrhea/enteropathy,hepas, developmental delay, dysmorphic facial features . ZAP-70 combined hypomorphic and acvaon mutaons. ZAP70. AR (LOF/GOF) Severe autoimmunity. Hyperacve Zap70 kinase. Decreased CD8. Tripepdyl-Pepdase II Deficiency. TPP2. AR. Variable lymphoproliferaon, severe autoimmune cytopenias, hypergammaglobulinemia, recurrent infecons. Decreased Tc and Bc. JAK1 GOF. JAK1. AD GOF. HSM, eosinophilia, eosinophilic enteris, thyroid disease, poor growth, viral infecons. Prolidase deficiency. PEPD. AR. Autoanbodies common, chronic skin ulcers, eczema, infecons 10 secreon. IL-10Ra deficiency. IL10RA AR. Folliculis, recurrent respiratory diseases, IL-10Rb deficiency. IL10RB.AR. arthris, lymphoma. Leukocytes unresponsive to IL10, IL22, IL26, IL28A, IL28B, IL29 NFAT5 haploinsufficiency. NFAT5. AD. CTLA4 deficiency (ALPSV). CTLA4. AD. Autoimmune cytopenias, enteropathy, intersal lung disease, extra-lymphoid lymphocyc infiltraon recurrent infecons . Impaired funcon of Tregs. Tc and Bc decreased. lymphoma. Folliculis, recurrent respiratory diseases, CD25 deficiency. IL2RA. AR. Lymphoproliferaon, autoimmunity, impaired Tc proliferaon. No CD4+C25+ cells with impaired funcon of Tregs cells. arthris, Leukocytes unresponsive to IL-10. Recurrent Sinopulmonary infecons. Decreased memory Bc and plasmablasts. BACH2 deficiency. BACH2. AD. Lymphocyc colis, sinopulmonary infecons. Impaired memory Bc development. Progressive Tc lymphopenia. Fig. 4 (continued) Fig. 5 Congenital defects of phagocyte number, function, or both. a„ Neutropenia. b Functional defects of phagocytes. AD: autosomal dominant transmission; AML: acute myeloid leukemia; AR: autosomal recessive transmission; BCG: Bacillus Calmette-Guerin; CD: cluster of differentiation; CGD: chronic granulomatous disease; CMF: flow cytometry; CMML: chronic myelomonocytic leukemia; def: deficiency; DHR: dihydrorhodamine-1,2,3; GOF: gain-of-function; IUGR: intrauterine growth retardation; MDS: myelodysplasia; NBT: nitroblue of tetrazolium; NK: natural killer cells; WBC: white blood cells; XL: X-linked transmission > J Clin Immunol (2018) 38:129–143 137 V. Congenital defects of phagocyte number, funcon, or both. a : Neutropenia( without an-PMN ) Syndrome associated No syndrome associated Shwachman-Diamond syndrome. SBDS. AR. DNAJC21. AR. Pancytopenia, exocrine pancreac insufficiency, chondrodysplasia Elastase deficiency (SCN1). ELANE. AD. Suscepbility to MDS/leukemia. Severe congenital G6PC3 deficiency (SCN4). G6PC3. AR. Structural heart defects, urogenital abnormalies, inner ear deafness, and venous angiectasias of trunks and limbs. Affected ns: Myeloid differenaon, chemotaxis, O 2- producon. neutropenia or cyclic neutropenia (perform CBC twice weekly/ 4 weeks). Glycogen storage disease type 1b. G6PT1. AR. Fasng hypoglycemia, lacc acidosis, hyperlipidemia, hepatomegaly. HAX1 deficiency (Kostmann Disease) (SCN3). HAX1. AR. Cognive and neurological defects in Cohen syndrome. COH1. AR. Dysmorphism, mental retardaon, obesity, deafness. paents with defects in both HAX1 isoforms, Barth Syndrome (3-Methylglutaconic aciduria type II). TAZ. XL. Cardiomyopathy, myopathy, growth retardaon. suscepbility to MDS/leukemia GFI 1 deficiency (SCN2). GFI1. AD. Clericuzio syndrome (Poikiloderma with neutropenia). C16ORF57 (USB1). AR. Renopathy, developmental delay, facial dysmorphism, poikiloderma. B/T lymphopenia VPS45 deficiency (SCN5). VPS45. AR. Extramedullary hematopoiesis, bone marrow fibrosis, nephromegaly. X-linked neutropenia/ myelodysplasia WAS GOF. WAS. Myeloid maturaon arrest, monocytopenia, P14/LAMTOR2 deficiency. LAMTOR2. AR. Paral albinism, growth failure. Hypogammaglobulinemia, reduced CD8 cytotoxicity. variable lymphoid anomalies . JAGN1 deficiency. JAGN1. AR. Osteopenia. Myeloid maturaon arrest. G-CSF receptor deficiency. CSF3R. AR. 3-Methylglutaconic aciduria. CLPB. AR. Neurocognive developmental aberraons, microcephaly, hypoglycemia, hypotonia, ataxia, seizures, cataracts, IUGR. Stress granulopoiesis disturbed Neutropenia with combined immune deficiency. SMARCD2 deficiency. SMARCD2. AR. Developmental aberraons, bones defect, myelodysplasia MKL1. AR. Mild thrombocytopenia. Lymphopenia. WDR1 deficiency. WDR1. AR. Poor wound healing, severe stomas, neutrophil nuclei herniate. Mild neutropenia. HYOU1 deficiency. HYOU1. AR. Hypoglycemia, inflammatory complicaons. V. Congenital defects of phagocyte. b : Funconal defects No Syndrome associated: DHR assay (or NBT test)? Syndrome associated Cystic fibrosis. CFTR. AR. Pancreatic insufficiency, Respiratory infections, elevated sweat chloride Papillon-Lefèvre . CTSC. Periodontitis, palmoplantar hyperkeratosis Localized juvenile periodontitis . FPR1. Periodontitis only β-Actin . ACTB Mental retardation. Leukocyte adhesion deficiency. Skin infections evolve to large ulcers. Leukocytosis with neutrophilia (WBC > 25000) LAD I . ITGB2 Delayed cord separation with omphalitis+++, no pus formation, lack of inflammation is observed in infection area. Periodontitis leads to early loss of teeth. , CD18 def (CMF) severity of the disease correlates with the degree of deficiency in CD18. (WBC 20,000– 150,000 with 60–85 % neutrophils) LAD II. SLC35C1 Extremely rare. Recurrent infections. Severe growth delay and severe intellectual deficit. Facial dysmorphism ( depressed nasal bridge). Severe periodontitis later in life. Bombay blood group. Infections: rarely life threatening. Patients may live to adulthood. LAD III. FERMT3 Severe bacterial infections and severe bleeding disorder; osteopetrosis (severe cases). Platelet aggregation assay. Normal GATA2 def (MonoMac sd) . GATA2, AD. Susceptibility to Mycocbacteria, Papilloma Viruses, Histoplasmosis, Lymphedema. Pulmonary alveolar proteinosis, myelodysplasia/AML/ CMML . Monocytopenia. Low NK. Specific granule deficiency. C/EBPE. Bilobed nuclei Pulmonary alveolar proteinosis. CSF2RA, AR. CSF2RB, XL. Affected cells: Alveolar macrophages. Affected fonction: GM-CSF signaling Abnormal CGD. Early onset of severe and recurrent infections affecting initially the natural barriers of the organism ( lungs, lymph nodes, skin), and eventually inner structures (liver, spleen, bones, brain, and +++ hepatic abscess). Autoinflammatory phenotype, IBD Granulomas obstructing respiratory, urinary or gastrointestinal tracts. Inflammatory bowel disease (Crohn’s like disease) and perianal disease : up to 30 % Pathogens : typically catalase positive bacteria (S. aureus and gram-negative bacilli, Aspergillus, Candida); other: Burkholderia cepacia,Chromobacterium violaceum, Nocardia, and invasive Serratia marcescens. In developing countries, BCG : adverse effects in up to 20 %. Microscopic granulomas. XL CGD: CYBB (gp91phox) NCF1 (p47phox) , AR CYBA (p22phox), AR NCF4 (p40phox), AR NCF2 (p67phox), AR Rac 2 def . RAC2. Poor wound healing. LAD phenotype. G6PD def Class I. G6PD. Reduced DHR. Infections. 138 J Clin Immunol (2018) 38:129–143 VI. Defects in Intrinsic and Innate immunity. a : Bacterial and Parasic Infecons Predisposion to Invasive Bacterial infecons (pyogens): Predisposion to Parasic and Fungal infecons meningis, sepsis, arthris, osteomyelis and abscesses, oen in the absence of fever. Predisposion to Mucocutaneous Candidiasis (CMC) Predominant pathogens (S. pneumoniae, S. aureus and Chronic Mucocutaneous Candidiasis without ectodermal dysplasia Pseudomonas aeruginosa). Non-invasive bacterial infecons (skin CARD9 def. CARD9, AR. Predisposion to INVASIVE Fungal Diseases. infecons and upper respiratory tract infecons). Improve with age. STAT1 GOF. STAT1, AD Invasive candidiasis Roune Usual screening tests are normal. Specific screening tests various fungal, bacterial and viral infecon, deep (lack of proinflammatory cytokine producon and CD62L shedding) : (HSV) infecons, autoimmunity dermatophytoses, (thyroidis, diabetes, cytopenias), other invasive fungal enteropathy infecons. IRAK4 def . IRAK4, AR IL-17F deficiency. MyD88 def . MYD88, AR. IL17F, AD. Folliculis. Trypanosomiasis. APOL1, AD IRAK-1 def. IRAK1, XL. IL-17RA deficiency. X-linked MECP2 deficiency-related syndrome due to a large de novo IL17RA, AR available only in specialized clinical immunology laboratories. Others Osteopetrosis. TNFRSF11A, PLEKHM1 AR. TCIRG1, AR. + hypocalcemia CLCN7, OSTM1, AR. + hypocalcemia, neurologic features SNX10, AR. + visual impairment TNFSF11, AR. + severe growth retardaon Hydradenis suppurava. PSENEN, AD. Inborn Errors of Xq28 chromosomal deleon encompassing both MECP2 and IRAK1 Folliculis. Suscepbility to S. aureus (skin infecons) TIRAP def. TIRAP, AR. Staphylococcal disease during childhood. Isolated congenital asplenia. IL-17RC deficiency. IL17RC, AR. ACT1 deficiency. ACT1, AR. Bacteremia (encapsulated bacteria). No spleen. Blepharis, folliculis and RPSA, AD macroglossia. HMOX, AR. Hemolysis, nephris, inflammaon Fig. 6 Defects in intrinsic and innate immunity. a Bacterial and parasitic infections. b MSMD and viral infection. AD: autosomal dominant transmission; AR: autosomal recessive transmission; BCG: Bacillus Calmette-Guerin; CD: cluster of differentiation; CMC: chronic mucocutaneous candidiasis; GOF: gain-of-function; IFNg: interferon- Immunity Related to Non-Hematopoiec NCSTN, AD. + acne PSEN, AD. + hyperpigmentaon Tissues Acute liver failure due to NBAS def. NBAS, AR. Fever induces liver failure Acute necrozing encephalopathy. RANBP2, AD. Fever induces acute encephalopathy gamma; HHV6: human herpes virus type 6; HPV: human papilloma virus; HSV: herpes simplex virus; LOF: loss-of-function; MSMD: Mendelian susceptibility to mycobacterial disease; NK: natural killer cells; RNA: ribonucleic acid; sd: syndrome; Tc: T cells; TLR3: Toll-like receptor type 3; VZV: varicella zoster virus; XL: X-linked transmission J Clin Immunol (2018) 38:129–143 139 VI. Defects in Intrinsic and Innate immunity. Mendelian Suscepbility to mycobacterial disease (MSMD) Severe phenotypes. Moderate phenotypes. b : MSMD and Viral infecon Predominant suscepbility to viral infecon Epidermodysplasia Predisposion to Severe Viral Infecon Herpes simplex Encephalis. STAT1 Def (AR LOF). STAT1. (+ Mycobacteria) Dominant clinical phenotype is Herpes simplex encephalis (HSE) during primary infecon with herpes simplex virus type 1 (HSV1), usually between 3 months and 6 years of age. Incomplete clinical penetrance for all eologies listed here. verruciformis (HPV) Complete IFNGR1 Def and IFNGR2 Def. With Suscepbility to Salmonella EVER1 def. IFNGR1, IFNGR2. AR. IL-12 and IL-23 receptor b1 chain deficiency. IL12RB1 .AR. IL-12p40 (IL-12 and IL-23) def. IL12B .AR. Serious disseminated STAT1 LOF. STAT1(AD) BCG and environmental Paral IFNγR1. IFNGR1. AR. Paral IFNγR2. IFNGR2.AR. TMC6.AR. STAT2 deficiency. STAT2. AR. Disseminated vaccinestrain measles EVER2 def. mycobacterial infecons (so ssue, bone Salmonella spp., Listeria monocytogenes and viruses (Warts, Hypogammaglobuline Tyk2 deficiency. TYK2. AR. Suscepbility to viruses, +/- elevated IgE. Mulple cytokine signaling defect. kathexis) sd. ISG15 Def. ISG15. AR. Brain calcificaon. IFNg producon defect. Macrophage gp91 phox deficiency. CYBB, XL IRF8 deficiency. IRF8 AD IRF8 deficiency. IRF8 AR Mulple other infecous agents. Myeloproliferaon RORc deficiency. RORC AR. Suscepbility to Candida. IFNg producon defect, complete absence of IL-17A/F-producing Tc JAK1 (LOF). JAK1. AR. Suscepbility to viruses, urothelial carcinoma. IFNg producon. Fig. 6 (continued) WHIM AD IFNGR1. IFNGR1. AD. Mycobacterial osteomyelis marrow, lungs, skin, bones and lymph nodes), TMC8. AR. IRF7 deficiency. IRF7. AR. Severe influenza disease. Defect of IFN-α,β and γ producon and IFNproducon mia, infecons, myelo- CXCR4 AD GOF. Warts (HPV) infecon, neutropenia, low B cell number, hypogammaglobulinemia. IFNAR2 deficiency. IFNAR2 AR. Disseminated vaccinestrain measles, HHV6. No response to IFN-α. CD16 deficiency. FCGR3A. AR. Severe herpes viral infecons, parcularly VZV, Epstein Barr virus (EBV), and HPV. Roune screening tests are normal. Specific tests examining the TLR3 pathway : marked decrease in the ability of paent’s fibroblasts to produce IFNα and β in response to HSV1 infecon. TLR3 (AD,AR), UNC93B1 (AR), TRAF3 MDA5 deficiency (LOF). IFIH1. AR. Rhinovirus and other RNA viruses (AD), TICAM1 (TRIF) (AR,AD), TBK1 (AD), IRF3 (AD). 140 J Clin Immunol (2018) 38:129–143 VIIa. Auto-inflammatory disorders Recurrent inflammaon Systemic inflammaon with urcaria rash Others Recurrent fever Familial Mediterranean Fever (FMF) *. MEFV. AR or AD DA: 1–4 days FA : Variable. Polyserosis, Abdominal pain, Arthris, Amyloidosis. Erysipelas-like erythema. Predisoposes to vasculis and inflammatory bowel disease Colchicine-responsive +++. Mevalonate kinase def* (Hyper IgD sd). MVK. AR DA: 3–7 days FA: 1–2 monthly. Cervical adenopathy. Oral aphtosis. Diarrhea. Mevalonate aciduria during aacks. Leukocytosis with high IgD levels. TNF receptor-associated periodic syndrome; TRAPS. TNFRSF1A. AD. DA: 1-4 weeks FA : Variable Prolonged fever. Serosis, rash, Periorbital edema and conjuncvis; Amyloidosis. Joint inflammaon. Familial Cold Autoinflammatory Syndrome (CAPS) * . NLRP3, NLRP12. AD GOF DA: 24-48H Non-pruric urcaria, arthris, chills, fever and leukocytosis a er cold exposure. Muckle Wells syndrome (CAPS) *. NLRP3. AD GOF. Ethnic group : North European Connuous fever. O en worse in the evenings. Deafness (SNHL), Conjuncvis, Amyloidosis. Neonatal onset mulsystem inflammatory disease (NOMID) or chronic infanle neurologic cutaneous and arcular syndrome (CINCA) *. NLRP3. AD GOF. Neonatal onset rash, with connuous fever and inflammaon. Asepc and chronic meningis, Deforming arthropathy, Mental retardaon. Sensorineural deafness. Visual loss. PLAID (PLCg2 associated anbody deficiency and immune dysregulaon), or APLAID*. PLC2G. AD GOF. Cold Urcaria. Autoimmunity. Blistering skin lesion, pulmonary and bowel disease. Hypogammaglobulinemia, autoinflammaon. NLRP1 deficiency*. NLRP1. AR. Dyskeratosis, autoimmunity and arthris. CANDLE sd (chronic atypical neutrophilic dermas with lipodystrophy). PSMB8, AR and AD. (Variants in PSMB4, PSMB9, PSMA3, and POMP ) Contractures, panniculis, ICC, fevers. COPA defect. COPA. AD Autoimmune inflammatory arthris and intersal lung disease with Th17 dysregulaon and autoanbody producon NLRC4-MAS (macrophage acvang syndrome)*. NLRC4. AD GOF. Severe enterocolis and macrophage acvaon syndrome (HLH). Triggered by cold exposure. A20 haploinsufficiency. TNFAIP3. AD LOF. Early onset systemic inflammaon, Arthralgia/arthris, oral/genital ulcers, ocular inflammaon. Fig. 7 a, b Autoinflammatory disorders. *Diseases affecting the inflammasome. AD: autosomal dominant transmission; AR: autosomal recessive transmission; BSN: bilateral striatal necrosis; CAPS: cryopirinassociated periodic syndrome; DA: duration of inflammation episode; FA: frequency of inflammation episode; FCL: familial chilblain lupus; GOF: gain-of-function; HLH: hemophagocytic lymphohistiocytosis; HSM: hepatosplenomegalia; ICC: intracranial calcifications; IL: interleukin; LOF: loss-of-function; sd: syndrome; SLE: systemic lupus erythematosus; SMS: Singleton-Merten syndrome; SNHL: sensorineural hearing loss; SP: spastic paraparesis; TORCH: toxoplasmosis, other, rubella, cytomegalovirus, and herpes infections J Clin Immunol (2018) 38:129–143 141 VIIb. Auto-inflammatory disorders Sterile inflammaon ( skin / bone / joints ) Predominant on the bone / joints Pyogenic sterile arthris, pyoderma gangrenosum, acne (PAPA) syndrome, hyperzincemia and hypercalprotecnemia. PSTPIP1 (C2BP1). AD Predominant on the skin Blau syndrome. NOD2 (CARD15). AD. Connuous inflammaon. Uveis, Granulomatous synovis, Camptodactyly, Rash, Cranial neuropathies, 30% develop Crohn colis. Sustained modest acute-phase response. DA: 5 days FA: Fixed interval : 4-6 weeks CAMPS. CARD14. AD. Psoriasis. Sterile pyogenic arthris, Pyoderma gangrenosum, inflammatory skin rash, Myosis. Acute-phase response during aacks Chronic recurrent mulfocal osteomyelis and congenital dyserythropoiec anemia (Majeed syndrome). LPIN2. AR DA : Few days FA : 1-3 / month Chronic recurrent mulfocal osteomyelis, severe pain, tender so ssue swelling, Transfusion-dependent anemia, cutaneous inflammatory disorders DITRA. (Deficiency of IL-36 receptor antagonist). IL-36RN. AR . Life-threatening, mulsystemic inflammatory disease characterized by episodic widespread, pustular psoriasis, malaise, and leukocytosis. ADAM17 deficiency. ADAM17 . AR. Early-onset pustular dermas, short and broken hair, paronychia, frequent cutaneous bacterial infecons, and Early onset diarrhea , high IL-1 and IL-6 producon. Lack of TNF-α was considered partly responsible for their increased suscepbility to infecon and development of cardiomyopathy. SLC29A3 mutaon. SLC29A3 . AR. DIRA (Deficiency of the Interleukin 1 Receptor Antagonist). IL1RN. AR Connuous inflammaon. Neonatal onset of sterile mulfocal osteomyelis, perioss and pustulosis. Cherubism. SH3BP2. AR. Bone degeneraon in jaws Fig. 7 (continued) Hyperpigmentaon hypertrichosis, Rosai-Dorfman like hisocytosis-lymphadenopathy plus H syndrome Otulipenia/ORAS. OTULIN. AR. Arthralgia, Fever, diarrhea , dermas. Lipodystrophy, myalgia, Neutrophilia AP1S3 deficiency. AP1S3. AR. Pustular psoriasis Type 1 Interferonopathies Progressive encephalopathy, ICC, Cerebral atrophy, HSM, leukodystrophy , Thrombocytopenia, Elevated hepac transaminases . Chronic cerebrospinal fluid (CSF) lymphocytosis Aicardi-Goueres syndrome. TREX1 AR-AD (+SLE, FCL), RNASEH2A, RNASEH2B (+SP), RNASEH2C, SAMHD1 (+ Skin vascularis, mouth ulcers, arthropathy, FCL), ADAR1 (+BSN, SP), IFIH1 GOF AD (+ SLE, SP, SMS) Spondyloenchondro-dysplasia dysregulaon (SPENCD). ACP5. with immune Possibly recurrent bacterial and viral infecons, SLE-like auto-immunity (Sjögren's syndrome, hypothyroidism, inflammatory myosis, Raynaud's disease and viligo), hemolyc anemia, thrombocytopenia, skeletal dysplasia, short stature, SP, ICC. STING-associated vasculopathy, infanle-onset. TMEM173. Early-onset inflammatory disease, Skin vasculopathy, inflammatory lung disease, systemic autoinflammaon and ICC, FCL. ADA2 deficiency. CECR1. Polyarteris nodosa, childhoodonset, early-onset recurrent ischemic stroke and fever, Livedo racemosa, low IgM, Hypogammagl, Lymphopenia XL reculate pigmentary disorder. POLA1. Hyperpigmentaon, reculate paern. Inflammatory lung and Gastroenteris or colis. Corneal scarring, characterisc facies USP18 def . USP18. TORCH like syndrome. 142 J Clin Immunol (2018) 38:129–143 VIII. Complement deficiencies Suscepbility to infecons Low High Disseminated Neisserial infecons Absent CH50 and AH50 hemolyc acvity. Defecve bactericidal acvity. Normal CH50. Absent AH50 hemolyc acvity C5 def. C5 Properdin def. PFC. XL C6 def. C6 C7 def . C7. + Vasculis C8 def. C8A, C8B, C8G C9 def. C9. Mild suscepbility. SLE-like syndrome. Recurrent pyogenic infecons C3 LOF. C3. AR. Absent CH50 and AH50 hemolyc acvity, defecve opsonizaon and humoral response C1q def. C1QA, C1QB, C1QC. C1r def. C1R. Ehlers Danlos spontaneous AH50 def. Infecons mainly in the lungs; abscesses, necrozing enterocolis in infancy; selecve anbody defect to Pneumococcal polysaccharides. Absence of complement acvaon by the Ficolin 3 pathway Mulple autoimmune diseases; Ehlers Danlos phenotype C2 def. C2. Infecons, disseminated neisserial infecons, preeclampsia. Spontaneous acvaon of the alternave complement pathway with consumpon of C3 Vasculis, Polymyosis, atherosclerosis Factor H –related protein deficiencies. CFHR1-5. AR or AD. C4 def .C4A, C4B.AR. Later onset, disseminated neisserial infecons. Normal CH50, AH50, autoanbodies to Factor H. Paral deficiency is common (either C4A or C4B) and appears to have a modest effect on host defense disseminated neisserial infecons, preeclampsia. Spontaneous acvaon of the alternave complement pathway with consumpon of C3 C1 inhibitor. SERPING1. AD, Hereditary angioedema. Spontaneous acvaon of the complement pathway with consumpon of C4/C2 Membrane A ack Complex Inhibitor deficiency. CD59. Hemolyc anemia. Polyneuropathy. CD55 deficiency (CHAPLE disease). CD55. AR. Protein losing enteropathy, thrombosis Membrane Cofactor Protein deficiency. CD46.AD,Glomerulone- encapsulated organisms. Deficient v n of the alternave pathway Fig. 8 Complement deficiencies. AD: autosomal dominant transmission; AH50: alternate pathway hemolytic activity; AR: autosomal recessive transmission; CH50: complement hemolytic activity; def: deficiency; Factor I deficiency. AR. Infecons, Others Thrombomodulin def. THBD. AD. Normal CH50, AH50 Factor B. CFB LOF. AR. Infecons with Fig. 9 Phenocopies of PID. ALPS: autoimmune lymphoproliferative syndrome; AutoAb: auto-antibodies; CID: combined immunodeficiency; CMC: chronic mucocutaneous candidiasis; GOF: gain-offunction; MSMD: Mendelian susceptibility to mycobacterial disease; PRCA: pure red cell aplasia Factor B GOF. CFB. AD. Increased phenotype C1s def.C1S. Inflammatory lung disease, autoimmunity Ficolin 3 FCN3. AR. C3 GOF. C3. AD. Infecons , glomerulonephris. Increased acvaon of complement Factor H def. CFH. AR or AD. MASP2 def. MASP2. AR. Factor D def. CFD. AR. Atypical Hemolyc Uremic Syndrome Infecons with encapsulated organisms Absent CH50 hemolyc acvity phris. Infecons, preeclampsia . Inhibitor of complement alternate pathway, decreased C3b binding LOF: loss-of-function; sd: syndrome; SLE: systemic lupus erythematosus; XL: X-linked transmission IX. Phenocopies of PID Associated with Somatic Mutations Splenomegaly, lymphadenopathy, autoimmune cytopenias. Defecve lymphocyte apoptosis. ALPS-SFAS. (somac mutaons in TNFRSF6)/ ALPS-FAS (ALPS type Im) RALD. RAS-associated autoimmune leukoproliferave disease. (ALPS Like); N-RAS GOF, K-RAS GOF Sporadic; granulocytosis, monocytosis/ALPS-like Cryopyrinopathy, (Muckle-Wells /CINCA/NOMID-like syndrome). NRLP3. Urcaria-like rash, arthropathy, neurological symptoms Associated with Auto-Antibodies Chronic mucocutaneous candidiasis (isolated or with APECED syndrome). AutoAb to IL-17 and/or IL-22. Endocrinopathy, chronic mucocutaneous candidiasis /CMC. Germline mutaon in AIRE Adult-onset immunodeficiency with suscepbility to mycobacteria. Auto-Ab to IFNg. Mycobacterial, fungal, salmonella, VZV infecons / MSMD or CID. Recurrent skin infecon. AutoAb to IL-6. Staphylococcal infecons / STAT3 deficiency Pulmonary alveolar proteinosis . AutoAb to GM-CSF. Pulmonary alveolar proteinosis, cryptococcal meningis, disseminated nocardiosis/CSF2RA deficiency Hypereosinophilic syndrome due to somac mutaons in STAT5b. STAT5b. GOF. Acquired angiooedema . AutoAb to C1 inhibitor. Angioedema /C1 inhibitor deficiency Atopic dermas, urcarial rash, diarrhea. Eosinophilia. Atypical Hemolyc Uremic Syndrome . AutoAb to Factor H. Spontaneous acvaon of the alternave complement pathway Thymoma with hypogammaglobulinemia (Good syndrome). AutoAb to various cytokines. Invasive bacterial, viral or opportunisc infecons, autoimmunity, PRCA, lichen planus, cytopenia, colis, chronic diarrhea. No B cells. J Clin Immunol (2018) 38:129–143 Conflict of Interest The authors declare that they have no conflict of interest. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http:// creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. References 1. Picard C, Gaspar HB, Al-Herz W, Bousfiha A, Chatila T, Crow YJ, et al. International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee report on inborn errors of immunity. J Clin Immunol 2017(in Press). 143 2. Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2013;33(1): 1–7. 3. Kobrynski L, Powell RW, Bowen S. Prevalence and morbidity of primary immunodeficiency diseases, United States 2001-2007. J Clin Immunol. 2014;34(8):954–61. 4. Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside. J Clin Immunol. 2013;33(6):1078–87. 5. Jeddane L, Ouair H, Benhsaien I, El Bakkouri J, Bousfiha AA. Primary immunodeficiency classification on smartphone. J Clin Immunol. 2017;37(1):1–2.